{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:33:03Z","timestamp":1759411983387},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142090","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T18:49:39Z","timestamp":1446749379000},"page":"e0142090","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunization with a Double-Mutant (R192G\/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model"],"prefix":"10.1371","volume":"10","author":[{"given":"M. John","family":"Albert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Haridas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Ebenezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Raghupathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"issue":"Suppl","key":"ref1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijfoodmicro.2010.01.021","article-title":"Food-borne diseases-The challenge of 20 years ago still persists while new ones continue to emerge","volume":"139","author":"DG Newell","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"ref2","first-page":"121","article-title":"Campylobacter","author":"CR Friedman","year":"2000"},{"key":"ref3","first-page":"139","article-title":"Campylobacter","author":"RA Oberhelman","year":"2000"},{"issue":"Suppl 2","key":"ref4","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1086\/513780","article-title":"Epidemiologic and clinical features of <italic>Campylobacter jejuni<\/italic> infections","volume":"176","author":"MJ Blaser","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"ref5","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1086\/513785","article-title":"The economic burden of <italic>Campylobacter<\/italic>-associated Guillain-Barre\u02b9 syndrome","volume":"176","author":"JC Buzby","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"ref6","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1086\/513791","article-title":"Vaccines against <italic>Campylobacter jejuni<\/italic>","volume":"176","author":"DA Scott","year":"1997","journal-title":"J. Infect. Dis"},{"key":"ref7","unstructured":"World Health Organization. State of the art of vaccine research and development. 2006. WHO\/IVB\/06.1. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/vaccines-documents\/\" xlink:type=\"simple\">www.who.int\/vaccines-documents\/<\/ext-link>"},{"issue":"3","key":"ref8","first-page":"1013","article-title":"Vaccines against <italic>Campylobacter jejuni<\/italic>","volume":"1","author":"MJ Albert","year":"2014","journal-title":"Austin J Clin Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1128\/IAI.00139-07","article-title":"Identification of a <italic>Campylobacter jejuni<\/italic> protein that cross-reacts with cholera toxin","volume":"75","author":"MJ Albert","year":"2007","journal-title":"Infect Immun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CVI.00471-07","article-title":"Major outer membrane proteins from many <italic>Campylobacter<\/italic> species cross-react with cholera toxin","volume":"15","author":"MJ Albert","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e00246","DOI":"10.1128\/mBio.00246-13","article-title":"Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model","volume":"4","author":"MJ Albert","year":"2013","journal-title":"mBio"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jmb.2010.11.060","article-title":"Crystal structures exploring the origins of the broader specificity of <italic>Escherichia coli<\/italic> heat-labile enterotoxin compared to cholera toxin","volume":"406","author":"A Holmner","year":"2011","journal-title":"J Mol Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/175.2.352","article-title":"Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic <italic>Escherichia coli<\/italic> for oral administration of inactivated influenza virus vaccine","volume":"175","author":"JM Katz","year":"1997","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0264-410X(95)80006-Y","article-title":"Safety and immunogenicity of a prototype oral whole-cell killed <italic>Campylobacter<\/italic> vaccine administered with a mucosal adjuvant in non-human primates","volume":"13","author":"S Baqar","year":"1995","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"LC Freytag","year":"2005","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole-cell <italic>Helicobacter pylori<\/italic> vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"K Kotloff","year":"2001","journal-title":"Infect Immun"},{"key":"ref17","first-page":"429","article-title":"Campylobacter","author":"DR Tribble","year":"2008"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CVI.00538-10","article-title":"Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G\/L211A), as a safe and effective oral adjuvant","volume":"18","author":"EB Norton","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/IAI.01407-12","article-title":"A double-mutant heat-labile toxin from Escherichia coli, LT (R192G\/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection","volume":"81","author":"L Sjokvist Ottsjo","year":"2013","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CVI.00036-10","article-title":"Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine","volume":"17","author":"YJ Lu","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/CVI.00464-13","article-title":"Saftety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic <italic>Escherichia coli<\/italic>","volume":"20","author":"SS El-Kamary","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/CVI.00255-10","article-title":"Recombinant PorA, the major outer membrane protein of <italic>Campylobacter jejuni<\/italic>, provides heterologous protection in an adult mouse intestinal colonization model","volume":"17","author":"A Islam","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1128\/IAI.64.12.4933-4939.1996","article-title":"Murine intranasal challenge model for the study of <italic>Campylobacter<\/italic> pathogenesis and immunity","volume":"64","author":"S Baqar","year":"1996","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/mdr.2009.0892","article-title":"Tetracycline resistance is frequent among <italic>Campylobacter jejuni<\/italic> isolates from Kuwait","volume":"15","author":"MJ Albert","year":"2009","journal-title":"Microb Drug Resist"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1128\/IAI.42.1.276-284.1983","article-title":"Identification and characterization of <italic>Campylobacter jejuni<\/italic> outer membrane proteins","volume":"42","author":"MJ Blaser","year":"1983","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1128\/IAI.68.10.5679-5689.2000","article-title":"Sequence polymorphism, predicted secondary structures, and surface-exposed conformational epitopes of <italic>Campylobacter<\/italic> major outer membrane protein","volume":"68","author":"Q Zhang","year":"2000","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/IAI.34.2.333-336.1981","article-title":"Isolation of special antibodies which react only with homologous enterotoxins from <italic>Vibrio cholerae<\/italic> and enterotoxigenic <italic>Escherichia coli<\/italic>","volume":"34","author":"T Honda","year":"1981","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0264-410X(98)00076-0","article-title":"Mucosal immunoadjuvant activity of the recombinant <italic>E<\/italic>. <italic>coli<\/italic> eat-labile enterotoxin and its B subunit: induction of systematic IgG and secretory IgA responses in mice by intranasal immunization with influenza surface antigen","volume":"20","author":"WR Verweij","year":"1998","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/AAC.37.12.2688","article-title":"Modulation of mucosal immunity against <italic>Campylobacter jejuni<\/italic> by orally administered cytokines","volume":"37","author":"S Baqar","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/IAI.00076-08","article-title":"Immunogenicity and protective efficacy of recombinant <italic>Campylobacter jejuni<\/italic> flagellum-secreted proteins in mice","volume":"76","author":"S Baqar","year":"2008","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1128\/IAI.69.6.4125-4128.2001","article-title":"Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans","volume":"69","author":"M Jertborn","year":"2001","journal-title":"Infect Immun"},{"key":"ref33","first-page":"20","article-title":"Campylobacter jejuni: current status and future trends","author":"D Taylor","year":"1992"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/infdis\/168.3.754","article-title":"<italic>Campylobacter<\/italic> immunity and quantitative excretion rates in Thai children","volume":"168","author":"DN Taylor","year":"1993","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3476(05)82652-6","article-title":"Protection of breast-fed infants against <italic>Campylobacter<\/italic> diarrhea by antibodies in human milk","volume":"116","author":"GM Ruiz-Palacios","year":"1990","journal-title":"J Pediatr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.1987.03390010047026","article-title":"The influence of immunity on raw milk-associated <italic>Campylobacter<\/italic> infection","volume":"257","author":"MJ Blaser","year":"1987","journal-title":"JAMA"},{"key":"ref37","first-page":"207","article-title":"Campylobacter jejuni: current status and future trends","author":"R Black","year":"1992"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-1097(97)00111-0","article-title":"Primary structure analysis and adhesion studies on the major outer membrane protein of <italic>Campylobacter jejuni<\/italic>","volume":"150","author":"W Schroder","year":"1997","journal-title":"FEMS Microbiol Lett"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.43.3.986-993.1984","article-title":"<italic>Campylobacter jejuni<\/italic> outer membrane proteins are antigenic for humans","volume":"43","author":"MJ Blaser","year":"1984","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/IAI.60.11.4938-4944.1992","article-title":"Human immune response to <italic>Campylobacter jejuni<\/italic> proteins expressed in vivo","volume":"60","author":"P Panigrahi","year":"1992","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1574-6968.2007.00752.x","article-title":"Infection-induced antibodies against the major outer membrane protein of <italic>Campylobacter jejuni<\/italic> may recognize conformational epitopes","volume":"272","author":"S Huang","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"ref42","first-page":"133","article-title":"Bacterial protein toxins","author":"WA Patton","year":"2000"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e51718","DOI":"10.1371\/journal.pone.0051718","article-title":"The adjuvant double mutant <italic>Escherichia coli<\/italic> heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens","volume":"7","author":"S Leach","year":"2012","journal-title":"PLoS ONE"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.4049\/jimmunol.1003789","article-title":"<italic>Escherichia coli<\/italic> heat-Labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production","volume":"186","author":"CF Brereton","year":"2011","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e15398","DOI":"10.1371\/journal.pone.0015398","article-title":"Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection","volume":"5","author":"LA Edwards","year":"2010","journal-title":"PLoS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:51:16Z","timestamp":1599785476000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142090"}},"subtitle":[],"editor":[{"given":"Niyaz","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142090","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}